![David Arthur](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Arthur
Vorstandsvorsitzender bei SALARIUS PHARMACEUTICALS, INC.
Vermögen: 22 750 $ am 31.05.2024
Profil
David J.
Arthur is currently the President, Chief Executive Officer & Director at Salarius Pharmaceuticals LLC since 2015 and at Salarius Pharmaceuticals, Inc. since 2019.
Previously, he worked as the Managing Director at Dacon Pharma LLC from 2012 to 2015.
Mr. Arthur holds an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
11.04.2024 | 49 135 ( 1,03% ) | 22 750 $ | 31.05.2024 |
Aktive Positionen von David Arthur
Unternehmen | Position | Beginn |
---|---|---|
SALARIUS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 19.07.2019 |
Salarius Pharmaceuticals LLC
![]() Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Vorstandsvorsitzender | 01.11.2015 |
Ehemalige bekannte Positionen von David Arthur
Unternehmen | Position | Ende |
---|---|---|
Dacon Pharma LLC | Corporate Officer/Principal | 01.10.2015 |
Ausbildung von David Arthur
North Carolina State University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SALARIUS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Salarius Pharmaceuticals LLC
![]() Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Health Technology |
Dacon Pharma LLC |